Devrim Çabuk
Impact in
-
- Prostate Cancer Treatment and Research
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment
-
- PARP inhibition in cancer therapy
Papers in
- Oncology 26
- HER2/EGFR in Cancer Research 8
- Colorectal Cancer Treatments and Studies 6
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer-related Molecular Pathways 4
- Lung Cancer Research Studies 3
-
- Advanced Breast Cancer Therapies 8
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Kazım Uygun (17 shared papers)Umut Kefeli (9 shared papers)Faysal Dane (7 shared papers)Atalay Doğru (1 shared paper)Tayfun Şahı̇n (1 shared paper)Hasan Şenol Çoşkun (4 shared papers)Gül Başaran (9 shared papers)Nazım Serdar Turhal (5 shared papers)
- Journals
- Journal of Chemotherapy (2 papers)Medicine (2 papers)Journal of Clinical Oncology (2 papers)ESMO Open (2 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- TürkiyeUnited KingdomUnited States
In The Last Decade
Devrim Çabuk
50 papers receiving 576 citations
Devrim Çabuk's Hit Papers
Peers
Comparison fields: 5 of 54
- Pulmonary and Respiratory Medicine 298
- Oncology 221
- Cancer Research 78
- Endocrinology, Diabetes and Metabolism 24
- Cellular and Molecular Neuroscience 27
Countries citing papers authored by Devrim Çabuk
This map shows the geographic impact of Devrim Çabuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devrim Çabuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devrim Çabuk more than expected).
Fields of papers citing papers by Devrim Çabuk
This network shows the impact of papers produced by Devrim Çabuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devrim Çabuk. The network helps show where Devrim Çabuk may publish in the future.
Co-authors
The 25 scholars most cited alongside Devrim Çabuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2023 | 240 |
| 2 | 2024 | 43 | |
| 3 | 2017 | 36 | |
| 4 | 2020 | 29 | |
| 5 | 2018 | 19 | |
| 6 | 2019 | 18 | |
| 7 | 2013 | 18 | |
| 8 | 2023 | 17 | |
| 9 | 2014 | 14 | |
| 10 | 2023 | 14 | |
| 11 | 2013 | 12 | |
| 12 | 2014 | 11 | |
| 13 | 2014 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2016 | 8 | |
| 17 | 2009 | 7 | |
| 18 | The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors. | 2017 | 6 |
| 19 | 2018 | 6 | |
| 20 | 2018 | 5 |
About Devrim Çabuk
Devrim Çabuk is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Surgery, having authored 59 papers that have together received 588 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (8 papers), Lung Cancer Treatments and Mutations (8 papers), Breast Cancer Treatment Studies (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Cancer-related Molecular Pathways (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (298 citations), Oncology (221 citations), Cancer Research (78 citations), Endocrinology, Diabetes and Metabolism (24 citations) and Cellular and Molecular Neuroscience (27 citations). Devrim Çabuk has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Kazım Uygun, Umut Kefeli, Faysal Dane, Atalay Doğru, Tayfun Şahı̇n, Hasan Şenol Çoşkun, Gül Başaran, Nazım Serdar Turhal, Senem Karabulut and Mehmet Artaç. Their work appears in journals such as Journal of Chemotherapy, Medicine, Journal of Clinical Oncology, ESMO Open and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.